Get started
Author

Polina S. Shilo

Observed names: P. S. SHILO, P. S. Shilo, P. Shilo, P.S. Shilo, P.S. Shilo () Shilo, Polina Shilo, П. С. Шило, Шило Полина Сергеевна
Observed institutions: Russian Academy of Sciences, First Pavlov State Medical University of St. Petersburg, Stockholm School of Economics in Russia, Institute of Cytology, Institute of Oncology NN Petrov, Ministry of Health of the Russian Federation
ORCID: 0009-0001-1482-4604
Observed ORCID: 0009-0001-1482-4604
OpenAlex ID: A5002663860
Experimental Model to Study the Role of Retinoblastoma Gene Product (pRb) for Determination of Adipocyte Differentiation
2015 · B. V. Popov, P. S. Shilo, et al. · Bulletin of Experimental Biology and Medicine · 3
Clinical application of next-generation sequencing in cancer patients.
2021 · Valentina Shamrikova, Polina Shilo, et al. · Journal of Clinical Oncology · 2
Abstract P3-12-12: Real-World Efficacy and Outcomes of CDK4/6 Inhibitors in HR+ Metastatic Breast Cancer: A Retrospective Analysis from Russia
2025 · Anastasia Danilova, Daniil Stroyakovsky, et al. · Clinical Cancer Research · 1
Dual immunotherapy with nivolumab and ipilimumab for metastatic melanoma: Real-world outcomes from a single-center study.
2025 · Alexandr Iurchenkov, Anastasia Danilova, et al. · Journal of Clinical Oncology · 1
Assessing the efficacy of ALK inhibitors in ALK-positive non-small cell lung cancer: A real-world data analysis.
2025 · Daniil Stroyakovskiy, Polina Shilo, et al. · Journal of Clinical Oncology · 1
Predictors of successful molecularly targeted therapy based on comprehensive genomic profiling data
2025 · Polina S. Shilo, Mariya L. Makarkina, et al. · Science and Innovations in Medicine · 1
Evidence blocks for effective presentation of genomic findings at molecular tumor boards: Single institution experience
2024 · Alexandra Lebedeva, Olesya Kuznetsova, et al. · Heliyon · 1
Применение панелей комплексного молекулярного профилирования при опухолях желудочно-кишечного тракта. Обзор литературы и собственные результаты
2023 · О. А. Кузнецова, М. Ю. Федянин, et al. · Malignant tumours · 1
PDF
Tumor immunity portrait: An AI-driven molecular predictor combining tumor microenvironment and tumor mutational burden for immune checkpoint inhibitor response prediction.
2023 · Polina Shilo, Artem Tarasov, et al. · Journal of Clinical Oncology · 1
PDF
Personalized therapy in solid tumors: results of a retrospective multicentre study of the clinical applicability of the FoundationOne® Medicine Test
2022 · M. L. Stepanova, O. A. Kuznetsovа, et al. · Surgery and Oncology · 1
PDF
Prospects for High-dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation in the First Line of Therapy for Aggressive Non-hodgkin’s Lymphomas
2017 · Larisa Filatova, Yevgeniya Kharchenko, et al. · Voprosy Onkologii · 1
PDF
Sequential Precision Therapy Strategy for ARID1A / PIK3CA / ATM -Altered Gallbladder Cancer: A Case Report of Prolonged Stable Disease
2026 · Maria Makarkina, Olesya Kuznetsova, et al. · Journal of Medical Cases
PDF
Development and internal validation of a serum biomarker signature for non-small cell lung cancer: an exploratory case–control study
2026 · A. V. Zhilenkova, P. S. Shilo, et al. · Sechenov Medical Journal
PDF
Considerations in Genomic Therapy Matching
2026 · Polina Shilo · JAMA Oncology
Clinical utility and implementation of a virtual molecular tumor board in real-world oncology practice
2026 · Olesya Kuznetsova, Maria Cheporova, et al. · Cancer Genetics
Real-World Outcomes of Nivolumab Plus Ipilimumab in Metastatic Melanoma: A Stratified Analysis of First- and Second-Line Treatment
2026 · Alexandr Iurchenkov, Anastasia Danilova, et al. · Cancers
PDF
Real-world outcomes with nivolumab–ipilimumab in metastatic renal cell carcinoma by nephrectomy status: A single-center study.
2026 · Daniil Stroyakovskiy, Valeriy Shirokorad, et al. · Journal of Clinical Oncology
Routine targeted NGS testing to guide treatment decisions in all-stage NSCLC: Public hospital implementation.
2026 · Daniil Stroyakovskiy, Irina Demidova, et al. · Journal of Clinical Oncology
Maintenance therapy after induction chemotherapy with anti-EGFR–antibody and survival in metastatic colorectal cancer: A retrospective real-world study.
2026 · Polina Shilo, Anastasia Danilova, et al. · Journal of Clinical Oncology
Nivolumab plus ipilimumab with chemotherapy as first-line therapy for NSCLC: A single-center real-world experience.
2026 · Daniil Stroyakovskiy, Yana Akhmadiyarova, et al. · Journal of Clinical Oncology
PDF
Re: predictive modeling of treatment-related thyroid dysfunction and prognostic implication in advanced nasopharyngeal carcinoma with PD-1 inhibitors
2026 · Polina Shilo · The Oncologist
Abstract PS2-02-21: Real-world outcomes of CDK4/6 inhibitors in patients with metastatic invasive lobular carcinoma: a retrospective single-center study
2026 · A. Danilova, P. Shilo, et al. · Clinical Cancer Research
Deriving Real-World Evidence from Non-English Electronic Medical Records in Hormone Receptor-Positive Breast Cancer Using Large Language Models
2025 · Daur Meretukov, Katerina Grechukhina, et al. · Cancers
PDF
525 Real-world effectiveness of neoadjuvant immunotherapy in resectable stage III-IV melanoma: a comparative analysis of nivolumab/ipilimumab versus pembrolizumab
2025 · Alexandr Iurchenkov, Daniil Stroyakovskiy, et al. · Journal for ImmunoTherapy of Cancer
PDF
Real-world data on the treatment of patients with ROS1-positive non-small cell lung cancer.
2025 · Daniil Stroyakovskiy, Polina Shilo, et al. · Journal of Clinical Oncology
PDF
Works count: 49
Citation count: 14
H-index: 2
I10-index:
Year
Topic
Type